Doctor discusses what relaxed FDA rules mean for Alzheimer's sufferers

Print
Email
|

WFAA

Posted on March 14, 2013 at 9:05 PM

In exciting news for Alzheimer's patients and their families, the FDA plans to relax the rules for approving new treatments for the disease.

Dr. Gregg Shalan, a neurologist from Methodist Dallas Medical Center discusses what that decision means for those whose lives have been touched by Alzheimer's.

Print
Email
|
 
Health News Video
More Video